MICHAEL ALLEN: Open Payments
NPI 1376026252 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 73 payments from 8 companies in 2025. Trend: 2023 $465 · 2024 $644 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $470 |
| Vanda Pharmaceuticals Inc. | 15 | $204 |
| AstraZeneca Pharmaceuticals LP | 7 | $169 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $36 |
| Amgen Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| PFIZER INC. | 1 | $17 |
Products named: VRAYLAR, FANAPT, QULIPTA, AIRSUPRA, UBRELVY, TRELEGY ELLIPTA, OTEZLA, JARDIANCE.
Industry payments across KY — which companies pay providers there.
